Abstract
“How do drugs cross the plasma membrane?” this may seem like a trivial question. This question is often overlooked to focus primarily on the different complex macro-molecular aspects involved in drug delivery or drug resistance. However, recent studies have highlighted the theme that to be fully understood, more knowledge of the underlying biology of the most complex biological processes involved in the delivery and resistance to drugs is needed. After all, why would a drug interact with a transporter then subsequently be excluded from P-glycoprotein (P-gp) expressing drug resistant cells? What are the determinants of this transition in behavior? Full consideration of the physical biology of drug delivery has allowed a better understanding of the reasons why specific membrane proteins are upregulated or overexpressed in drug resistant cells. This, in turn, allows us to identify new targets for drug chemicals. Better yet, it increases the significance of recents patents and underlines their importance in multi drug resistance.
Keywords: Cell membrane, drug delivery, drug resistance, pharmacokinetics, physical biology, antitumor agents, diffusion, hydrophobicity, cytosolic pH
Recent Patents on Anti-Cancer Drug Discovery
Title: Teaching New Dogs Old Tricks: Membrane Biophysical Properties in Drug Delivery and Resistance
Volume: 6 Issue: 3
Author(s): Nina Milosavljevic, Adam Blanchard, Miriam L. Wahl, Salvador Harguindey, Mallorie Poet, Laurent Counillon and Cyril Rauch
Affiliation:
Keywords: Cell membrane, drug delivery, drug resistance, pharmacokinetics, physical biology, antitumor agents, diffusion, hydrophobicity, cytosolic pH
Abstract: “How do drugs cross the plasma membrane?” this may seem like a trivial question. This question is often overlooked to focus primarily on the different complex macro-molecular aspects involved in drug delivery or drug resistance. However, recent studies have highlighted the theme that to be fully understood, more knowledge of the underlying biology of the most complex biological processes involved in the delivery and resistance to drugs is needed. After all, why would a drug interact with a transporter then subsequently be excluded from P-glycoprotein (P-gp) expressing drug resistant cells? What are the determinants of this transition in behavior? Full consideration of the physical biology of drug delivery has allowed a better understanding of the reasons why specific membrane proteins are upregulated or overexpressed in drug resistant cells. This, in turn, allows us to identify new targets for drug chemicals. Better yet, it increases the significance of recents patents and underlines their importance in multi drug resistance.
Export Options
About this article
Cite this article as:
Milosavljevic Nina , Blanchard Adam, L. Wahl Miriam, Harguindey Salvador , Poet Mallorie, Counillon Laurent and Rauch Cyril, Teaching New Dogs Old Tricks: Membrane Biophysical Properties in Drug Delivery and Resistance, Recent Patents on Anti-Cancer Drug Discovery 2011; 6 (3) . https://dx.doi.org/10.2174/157489211796957829
DOI https://dx.doi.org/10.2174/157489211796957829 |
Print ISSN 1574-8928 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3970 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Progresses in TCM Metal-Based Antitumour Agents
Anti-Cancer Agents in Medicinal Chemistry One-Pot Synthesis of Triazolo-Heterolignans: Biological Evaluation and Molecular Docking Studies as Tubulin Inhibitors
Anti-Cancer Agents in Medicinal Chemistry High Throughput Screening Operations at the University of Kansas
Combinatorial Chemistry & High Throughput Screening Protein disulfide isomerase and Nox: new partners in redox signaling
Current Pharmaceutical Design Docetaxel (Taxotere) in the Treatment of Non-Small Cell Lung Cancer
Current Medicinal Chemistry From the Design to the Clinical Application of Thromboxane Modulators
Current Pharmaceutical Design Recent Advances in Use of Topoisomerase Inhibitors in Combination Cancer Therapy
Current Topics in Medicinal Chemistry Biological Activities and Corresponding SARs of Andrographolide and Its Derivatives
Mini-Reviews in Medicinal Chemistry Exploring Signaling Pathways and Pancreatic Cancer Treatment Approaches Using Genetic Models
Mini-Reviews in Medicinal Chemistry Gene Electrotransfer to Skin; Review of Existing Literature and Clinical Perspectives
Current Gene Therapy Author Index To Volume 6
Anti-Cancer Agents in Medicinal Chemistry Current Targeting Strategies for Adenovirus Vectors in Cancer Gene Therapy
Current Cancer Drug Targets An Unprecedented Revolution in Medicinal Chemistry Driven by the Progress of Biological Science
Current Topics in Medicinal Chemistry Efficacy of High-Dose Vitamin D Supplementation in the Critically Ill Patients
Inflammation & Allergy - Drug Targets (Discontinued) Novel Lactulose and Melibiose Targeting Autophagy to Reduce PolyQ Aggregation in Cell Models of Spinocerebellar Ataxia 3
CNS & Neurological Disorders - Drug Targets Synthetic and Natural Protease Inhibitors Provide Insights into Parasite Development, Virulence and Pathogenesis
Current Medicinal Chemistry Therapeutic Targeting of TRP Channels - The TR(i)P to Pain Relief
Current Topics in Medicinal Chemistry Clostridium Difficile Infection Following Chemotherapy
Recent Patents on Anti-Infective Drug Discovery Homocysteine and Cerebral Stroke in Developing Countries
Current Medicinal Chemistry Graphical Abstracts
Current Nanoscience